Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: Phenylalanine,3-[bis(2-chloroethyl)amino]-
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

1088-79-5

1088-79-5 structure

1088-79-5 structure

Name: Phenylalanine,3-[bis(2-chloroethyl)amino]-
Chemical Name: Phenylalanine,3-[bis(2-chloroethyl)amino]
CAS Number: 1088-79-5
Molecular Formula: C₁₃H₁₈Cl₂N₂O₂
Molecular Weight: 305.20000
Create Date: 2016-12-21 13:36:58
Modify Date: 2024-09-12 15:08:46

Name	Phenylalanine,3-[bis(2-chloroethyl)amino]
Synonyms	3-[Bis-(2-chlor-aethyl)-amino]-phenylalanin 3-[bis-(2-chloro-ethyl)-amino]-phenylalanine 3-<Bis-(2-chlor-aethyl)-amino>-oxanilsaeure-aethylester ethyl({3-[bis(2-chloroethyl)amino]phenyl}amino)(oxo)acetate

Density	1.32g/cm3
Boiling Point	479.7ºC at 760mmHg
Molecular Formula	C₁₃H₁₈Cl₂N₂O₂
Molecular Weight	305.20000
Flash Point	243.9ºC
Exact Mass	304.07500
PSA	66.56000
LogP	2.62530
Vapour Pressure	5.2E-10mmHg at 25°C
Index of Refraction	1.596

CHEMICAL IDENTIFICATION

RTECS NUMBER :: AY3380000

CHEMICAL NAME :: Alanine, 3-(m-(bis(2-chloroethyl)amino)phenyl)-, DL-

CAS REGISTRY NUMBER :: 1088-79-5

LAST UPDATED :: 198605

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C13-H18-Cl2-N2-O2

MOLECULAR WEIGHT :: 305.23

WISWESSER LINE NOTATION :: QVYZ1R CN2G2G -DL

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intracerebral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 625 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JPPMAB Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- Volume(issue)/page/year: 18,760,1966

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 10790 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986